BIOINFORMATICS
Bioinformatics is one of the most exciting branches of scientific exploration. With vast databases of multiomic and phenomic data becoming accessible we are now starting to reap the benefits of computer science and more
BIOINFORMATICS, Wednesday 4 December 2019
Registration and Refreshments
Chair’s opening remarks
Keynote [Reserved for Roche CEO]
Title Sponsor
Getting your data and applications ready for precision medicine
- Learn about key capabilities of the underlying reference architecture for high performance data and AI (HPDA) to manage the ocean of data and optimize your AI and big data pipelines for analysis.
- Understand how to improve data quality through advanced metadata management using content-based and policy-driven data classification & tagging.
- Discover how to support hybrid multicloud workload orchestration with end-to-end automation of workflows, leveraging containers and cloud using a self-service 'App Hub'.
- Hear about use cases from the world's fastest genomics pipeline to the largest variant database and explore how your organization can improve speed, scalability, collaboration and ease of use and gain significant cost efficiencies
New Frontiers in Data Science – the role of automation in accelerating scientific discovery
The future of data science at Janssen
Speed Networking
Morning refreshments
Roundtables
Accelerating operations and analytics with High Speed Data sharing across platforms and the world
Laurent Martin, Aspera Pre-Sales Engineer - EMEA, IBM Global Markets
Challenges in developing digital therapeutics
Joris Van Dam, Executive Director And Head Of Digital Therapeutics, Novartis
Data collection & algorithmic training for biomedical tasks: utilisation and strategies
Data Lakes, Getting data ready for analytics, and Personalized Health Data
Christian Blumenroehr, Principal Scientist, F. Hoffmann-La Roche
Data Privacy and Democratisation
Matthew Rooney, Chief Clinical Information Officer, Heart of England NHS Foundation Trust
Dell EMC
Design thinking: Driving forwards innovation in pharmaceuticals
Hermann Tribukait, Founder & CEO, ChemOS Inc.
Diagnosis based on genetic information and public ontologies and databases, improving the diagnosis process of rare disease patients with Foundation29
Enabling R&D via Clinical Trial data sharing (Data 42)
Philippe Marc, Global Head Of Integrated Data Sciences, Novartis Institutes for Biomedical Research
How Biodata Infrastructures enable Digital Entrepreneurs
IMI - EDHEN + BD4BO- The pro’s and con’s of the different IMI projects approaches. IT and high tech aspects. Gaining insights into the technical approaches to working with Real World Data at scale. Central vs. Federated; Working to promote FAIR principles
Matthew Wiener, Director, Informatics And Predictive Sciences, Celgene
Investing in AI in Genomics and Healthcare
Rick Dewey, Senior Director, Head Of Translational Genetics, Regeneron
Is bad User Experience (UX) hindering drug discovery? What are the challenges and opportunities for UX in life science software and digital transformation?
Ronald Johnston, Director Of Product And E-Commerce, Merck Digital
Lessons learned in running an AI-enabled operation for precision medicine – privacy, policy, and technical challenges and how we overcame them
NTT Data
Phage Display AI and Genomics – Using next generation AI and phage display to generate new immunological targets
Pushing the frontiers of AI. Accelerate your journey
Florin Manaila, Senior Architect - Cognitive Systems (Deep Learning, HPC), IBM Systems Europe
Rare diseases and digital innovation
Sandra Almeida, Global Strategic Planning Lead, Rare Diseases And Digital, Takeda
Reproducibility in Bioinformatics and Big Data Analytics: Myth or Reality?
Roche
Roche - All4IBD: a Digital Medicine Toolkit to transform care in Inflammatory Bowel Disease (IBD)
Sumanjit Sethi, Digital Health Leader, Immunology, Infectious Diseases and Ophthalmology, F. Hoffmann-La Roche Ltd
Roche - Analytical challenges with multimodal patient data: deriving drug development insights from clinico-molecular data
Gunther Jansen, Group Director, PHC Data Science Analytics, Roche
Roche - Digital Biomarkers – Endpoints in Clinical Trials
Christian Gossens, Digital Biomarker Informatics; Global Area Head; pRED Informatics, Roche
Showcases of Value and ROI with FAIR Data
Takeda
There is no AI without IA: Building a solid Information Architecture for your AI and high performance Precision Medicine
Frank Lee, PhD, Global Healthcare and Life Sciences Industry Leader, IBM Systems
Title TBC
Visualisation of good quality data and the pursuit of metrics to drive efficiencies in clinical trials
Paolo Piraino, Head Of Genomics And Biomarker Statistics, Bayer
Western Digital
Networking Lunch
Computational insight generation from population-level data in support of drug discovery programs
dotmatics
Sidra Bioinformatics Platform: towards advancing Genomic medicine in Qatar
Afternoon Refreshments
The dark matter of cancer genomics: Identifying unrecognizable structural variants in cancer genomes
Inferring tumor targets with machine-learning augmented pathway analysis
Abuse or Mis-use of RNA-seq Data Normalization in Practical RNA-seq Data Analysis
Afternoon Refreshments
Chairs remarks
SevenBridges
Patient journey in Oncology in 2025 - Molecular tumour boards in practice
Data visualization using JavaScript and R.
Drinks Reception
BIOINFORMATICS, Thursday 5 December 2019
Chair’s opening remarks
Presentation [Reserved Novartis CEO]
WuXiNextCode Presentation
Western Digital
Networking break
Roundtables
Analytical challenges with multimodal patient data: deriving drug development insights from clinico-molecular data
Gunter Jansen, Group Director, PHC Data Science Analytics, Roche
Data 42 Initiative – Data Integration
Philippe Marc, Global Head Of Integrated Data Sciences, Novartis Institutes for Biomedical Research
Data privacy sharing and analytics how technology can help
Andrew Roddam, Vice President And Global Head Epidemiology, GSK
DELL
Digital Biomarkers as endpoints in clinical trials: an opportunity for Personalised Healthcare
Christian Gossens, Digital Biomarker Informatics; Global Area Head; pRED Informatics, Roche
Educating data scientists for the pharmaceutical industry
Jake Chen, Chief Bioinformatics Officer, University of Alabama at Birmingham
IBM
IMI - The need for data communities in Europe, and why should you care? Looking ahead to an integrated European research meeting the need for RWD in a global environment.
Kiliana Suzart-Woischnik, Epidemiology Director, Bayer
In-hospital use of wearable sensors
Jens Eckstein, Cmio And Chief Physician, University Hospital Basel
Learnings and results from large-scale investments in data across the pharmaceutical R&D chain
Patients tech and health – Collaboration
Andrew Warrington, Project Leader - Digital Therapeutics Domain, Novartis
Precision Medicine in Practice
Real World Evidence vs. AI
Brigitte Fuhr, Head Of Data Science, Boehringer Ingelheim Pharma GmbH & Co. KG
Roche
Roche - All4IBD: a Digital Medicine Toolkit to transform care in Inflammatory Bowel Disease (IBD)
Sumanjit Sethi, Digital Health Leader, Immunology, Infectious Diseases and Ophthalmology, F. Hoffmann-La Roche Ltd
SCAT Project- UK Chemotherapy Database
Alice Turnbull, Programme Manager - Systemic Anti-Cancer Therapy Dataset, Public Health England
Stop talking about the principles, start showing what FAIR really means - Gaps in IT capabilities to support FAIR data and services
Wearable data and challenges around it that involve data ingestion, technology required for computation, data preprocessing and transformation and advanced analytics methods
Western Digital
IMI Lunchtime Panel- It is now or never! Connecting data communities with clinical research communities
- Building at scale communities
- Expanding the FAIR principles in the EU
- Understanding the quid pro quo between data partners and researcher
Lunch
Accelerating discovery with Functional Genomics data
Unlocking the potential of FAIR Data using AI
Afternoon Refreshments
Just Add Data Bio: Automating Machine Learning for Bioinformatics Predictive Analytics
D:WAVE
Demonstrating ROI on AI investment across a pharma company - concrete examples at Amgen
Afternoon Refreshments
Integrating AI into WGS at the forefront of clinical trials
Genetic studies at Novo Nordisk
Close of Conference
Contact us
To sponsor or exhibit contact:
Alistair Wilmot
+44 (0)207 092 1174
alistair.wilmot@terrapinn.com
To speak:
Chris Shanks
+44 (0)207 092 1151
chris.shanks@terrapinn.com
Organiser
